Volume 24, Number 7—July 2018
Research
Global Distribution of Human Protoparvoviruses
Table 3
Cohort | Age group, y | No. persons | No. (%) bufavirus IgG+ (95% CI) | p value | Mean age, y (range) |
---|---|---|---|---|---|
Finland | <40 | 165 | 1 (0.6) (0.0–3.7) | 0.096 | 31.6 (19–39) |
>40 | 149 | 5 (3.4) (1.2–7.8) | 49.7 (40–79) | ||
United States | <40 | 38 | 1 (2.6) (0.0–14.7) | 0.731 | 26.4 (18–39) |
>40 | 46 | 2 (4.3) (0.4–15.3) | 53.5 (40–72) | ||
Iraq | <40 | 45 | 40 (88.9) (76.1–95.6) | 0.325 | 30.8 (18–39) |
>40 | 54 | 44 (81.5) (69.0–89.8) | 47.2 (40–60) | ||
Iran | <40 | 54 | 21 (38.9) (27.0–52.2) | 0.0003 | 30.1 (18–39) |
>40 | 53 | 39 (73.6) (60.3–83.7) | 55.0 (40–77) | ||
Kenya | <40 | 52 | 37 (71.2) (57.7–81.8) | 0.890 | 29.5 (18–39) |
>40 | 65 | 47 (72.3) (60.4–81.8) | 54.3 (40–88) |
*The exact age of 2 adults from Kenya and 10 veterinarians from Finland were not known and they were excluded from the analysis. However, the 2 Kenyans were defined as adults in the overall prevalence calculations on the basis of education and marital status in the questionnaire. All veterinarians were defined as adults on the basis of work-related sample collection site. +, positive.
1Current affiliation: Finnish Food Safety Authority Evira, Helsinki, Finland.
2Current affiliation: University of Turku, Turku, Finland.
Page created: June 18, 2018
Page updated: June 18, 2018
Page reviewed: June 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.